High Dose Chemotherapy Followed By PBSC Rescue for HD

Stanford University

Status: Completed

Conditions: Hodgkin Disease

Treatments: Procedure: high dose chemo then auto hematopoietic cell transplant

Study type: Interventional

Funder types: Other

Identifiers

NCT00186251

BMT24

13322 (Other Identifier)

NCT00186251

Details and patient eligibility

About

To evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation in the treatment of Hodgkin's Disease.

Full description

Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease

Sex: All

Ages: 4 weeks to 70 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:- adequate organ function

• recurrent HD Exclusion Criteria:- CNS disease
• no prior malignancy

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)